Xiaohua Jie

699 total citations
17 papers, 474 citations indexed

About

Xiaohua Jie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaohua Jie has authored 17 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Xiaohua Jie's work include RNA modifications and cancer (4 papers), DNA Repair Mechanisms (3 papers) and Epigenetics and DNA Methylation (3 papers). Xiaohua Jie is often cited by papers focused on RNA modifications and cancer (4 papers), DNA Repair Mechanisms (3 papers) and Epigenetics and DNA Methylation (3 papers). Xiaohua Jie collaborates with scholars based in China. Xiaohua Jie's co-authors include Gang Wu, Xiaorong Dong, Rui Zhou, Shuangbing Xu, Yingzhuo Xu, Rui Meng, Xiaoshu Zhou, Xinrui Rao, Feng Fang and Ge Feng and has published in prestigious journals such as Cell Death and Differentiation, Cancer Letters and Cell Death and Disease.

In The Last Decade

Xiaohua Jie

17 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohua Jie China 12 300 168 128 110 64 17 474
Fengqing Fu China 11 260 0.9× 195 1.2× 165 1.3× 196 1.8× 46 0.7× 27 516
Zhenbo Tu China 14 328 1.1× 158 0.9× 106 0.8× 237 2.2× 82 1.3× 22 520
Ranjana Kanchan United States 12 242 0.8× 170 1.0× 198 1.5× 135 1.2× 52 0.8× 20 518
Tianjie Qin China 7 217 0.7× 170 1.0× 83 0.6× 82 0.7× 46 0.7× 9 403
Joanna Zabkiewicz United Kingdom 9 329 1.1× 99 0.6× 75 0.6× 70 0.6× 36 0.6× 18 484
Sara G. Manore United States 9 313 1.0× 256 1.5× 77 0.6× 126 1.1× 82 1.3× 13 579
Siti‐Faujiah Hendrayani Saudi Arabia 8 267 0.9× 339 2.0× 128 1.0× 89 0.8× 51 0.8× 8 532
Ahmed A. Quraishi United States 3 281 0.9× 385 2.3× 102 0.8× 148 1.3× 39 0.6× 4 529
Grace L. Wong United States 9 341 1.1× 229 1.4× 82 0.6× 150 1.4× 77 1.2× 13 578
He Hu China 10 165 0.6× 132 0.8× 55 0.4× 104 0.9× 56 0.9× 18 342

Countries citing papers authored by Xiaohua Jie

Since Specialization
Citations

This map shows the geographic impact of Xiaohua Jie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohua Jie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohua Jie more than expected).

Fields of papers citing papers by Xiaohua Jie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohua Jie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohua Jie. The network helps show where Xiaohua Jie may publish in the future.

Co-authorship network of co-authors of Xiaohua Jie

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohua Jie. A scholar is included among the top collaborators of Xiaohua Jie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohua Jie. Xiaohua Jie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Xue, Feng, Zilong Wu, Yongqiang Yang, et al.. (2024). USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase. Journal of Biomedical Science. 31(1). 55–55. 2 indexed citations
2.
Xue, Feng, Zilong Wu, Yongqiang Yang, et al.. (2024). Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis. Cell Death and Disease. 15(1). 104–104. 11 indexed citations
3.
Zhou, Dong, Tao Liu, Xinrui Rao, et al.. (2023). Targeting diacylglycerol kinase α impairs lung tumorigenesis by inhibiting cyclin D3. Thoracic Cancer. 14(13). 1179–1191. 2 indexed citations
4.
Rao, Xinrui, Dong Zhou, Jian Wang, et al.. (2023). Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury. Respiratory Research. 24(1). 25–25. 30 indexed citations
5.
Zhou, Xiaoshu, Rui Zhou, Xinrui Rao, et al.. (2022). Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer. Cell Death and Disease. 13(7). 636–636. 23 indexed citations
6.
Jie, Xiaohua, Zilong Wu, Xinrui Rao, et al.. (2022). REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis. Cell Death and Disease. 13(2). 110–110. 10 indexed citations
7.
Xu, Yingzhuo, Jian Wang, Xu Wang, et al.. (2022). Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors. Cell Death Discovery. 8(1). 36–36. 17 indexed citations
8.
Zeng, Zhen, Xiaohua Jie, Ye Wang, et al.. (2022). Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer. Cancer Letters. 532. 215594–215594. 23 indexed citations
9.
Rao, Xinrui, Xiaoshu Zhou, Geng Wang, et al.. (2022). NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer. Cell Death and Disease. 13(10). 891–891. 45 indexed citations
10.
Jie, Xiaohua, Ye Zhao, Yingzhuo Xu, et al.. (2022). Targeting KDM4C enhances CD8+ T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer. Journal for ImmunoTherapy of Cancer. 10(2). e003716–e003716. 40 indexed citations
11.
Wang, Jian, Yingzhuo Xu, Xinrui Rao, et al.. (2022). BRD4‐IRF1 axis regulates chemoradiotherapy‐induced PD‐L1 expression and immune evasion in non‐small cell lung cancer. Clinical and Translational Medicine. 12(1). e718–e718. 43 indexed citations
12.
Jie, Xiaohua, Rui Zhou, Ye Zhao, et al.. (2021). USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription. Cell Death and Differentiation. 28(7). 2095–2111. 60 indexed citations
13.
Zeng, Yulan, Xiaohua Jie, Bian Wu, et al.. (2020). IQGAP3 interacts with Rad17 to recruit the Mre11-Rad50-Nbs1 complex and contributes to radioresistance in lung cancer. Cancer Letters. 493. 254–265. 20 indexed citations
15.
Zhou, Xiaoshu, Rui Zhou, Qianwen Li, et al.. (2019). Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway. Anti-Cancer Drugs. 30(3). 241–250. 50 indexed citations
16.
Jie, Xiaohua, Xiong Peng, Ruiqi Fan, et al.. (2016). Rs3842530 Polymorphism in MicroRNA-205 Host Gene in Lung and Breast Cancer Patients. Medical Science Monitor. 22. 4555–5464. 7 indexed citations
17.
Jie, Xiaohua, et al.. (2011). Clinical Application of a Dendritic Cell Vaccine Raised Against Heat-Shocked Glioblastoma. Cell Biochemistry and Biophysics. 62(1). 91–99. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026